St Luke's Hospital is an NHS hospital in Bradford, West Yorkshire, England. It is situated on Little Horton Lane to the south-west of Bradford city centre. The hospital is managed by Bradford Teaching Hospitals NHS Foundation Trust. The main accommodation block is a grade II listed building.

During the past decade, St Lukes Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Lukes Hospital" #1 sponsor was "Abbott" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Ineos Healthcare Limited" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Lukes Hospital" #1 collaborator was "Arthritis Research UK" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St Lukes Hospital" are "Psoriatic Arthritis" (2 trials), "Actinic Keratosis (AK)" (1 trials), "Arthritis, Psoriatic" (1 trials), "Breast Cancer" (1 trials) and "Chronic Kidney Failure" (1 trials). Many other conditions were trialed in "St Lukes Hospital" in a lesser frequency.

Most popular intervention types in "St Lukes Hospital" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Atrasentan" (2 trials), "Adalimumab" (1 trials), "Anastrozole" (1 trials) and "BI 764198" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Lukes Hospital" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St Lukes Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in St Lukes Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St Lukes Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".